Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 3/20 | 0.45 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.45 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.41 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
| ▸ | MET | P08581 | 1/20 | 0.35 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.32 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1245098 | 1.00 | HIF1A (0.45) | HIF1AEPAS1OPRM1ACE2PTPN1 | |
| SCHEMBL29365925 | 1.00 | HIF1A (0.45) | HIF1AEPAS1OPRM1ACE2PTPN1 | |
| SCHEMBL1301000 | 1.00 | HIF1A (0.45) | HIF1AEPAS1OPRM1ACE2PTPN1 | |
| SCHEMBL31005385 | 1.00 | HIF1A (0.45) | HIF1AEPAS1OPRM1ACE2PTPN1 | |
| SCHEMBL10886590 | 0.89 | MET (0.48) | HIF1AEPAS1OPRM1ACE2PTPN1 | |
| SCHEMBL10886598 | 0.89 | MET (0.48) | HIF1AEPAS1OPRM1ACE2PTPN1 | |
| SCHEMBL12414369 | 0.80 | HIF1A (0.40) | HIF1AEPAS1OPRM1ACE2 | |
| SCHEMBL18339135 | 0.80 | HIF1A (0.40) | HIF1AEPAS1OPRM1ACE2 | |
| Methyl Alcohol SCHEMBL11309408 | 0.78 | OPRM1 (0.40) | HIF1AEPAS1OPRM1ACE2PTPN1 | |
| SCHEMBL18878241 | 0.77 | OPRM1 (0.39) | HIF1AEPAS1OPRM1ACE2PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2026-02-05 | — | — | US | disclosed |
| US-20260027136-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | YUZU LV LLC (US) | 2026-01-29 | — | — | US | disclosed |
| US-12485217-B2 | Contactless wound treatment barrier and method of contactless wound treatment | HACES ALBERTO (US) | 2025-12-02 | — | — | US | disclosed |
| US-12458653-B2 | Cannabis based therapeutic and method of use | YUZU LV LLC (US) | 2025-11-04 | — | — | US | disclosed |
| US-12427176-B2 | Enriched mineral pitch resin products and methods of manufacturing enriched mineral pitch resin products | RIZUN NODARI (US) | 2025-09-30 | — | — | US | disclosed |
| US-12303488-B2 | Cannabis based therapeutic and method of use | YUZU LV LLC (US) | 2025-05-20 | — | — | US | disclosed |
| US-20250025353-A1 | APPARATUS AND TREATMENT FOR WOUNDS AND MALODOROUS ODOR AND WOUNDS | HACES ALBERTO (US) | 2025-01-23 | — | — | US | disclosed |
| US-20240410055-A1 | METHOD AND FORMULATION FOR PREPARING OPTICAL METAL OXIDE LAYERS | MERCK PATENT GMBH (DE) | 2024-12-12 | — | — | US | disclosed |
| EP-4417252-A2 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | Yuzu LV LLC (US) | 2024-08-21 | — | — | EP | disclosed |
| US-20240216457-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-07-04 | — | — | US | disclosed |
| US-20150104398-A1 | TASTE MODULATOR AND METHOD OF USE THEREOF | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2015-04-16 | — | — | US | disclosed |
| US-20150050220-A1 | ANTIMICROBIAL COMPOSITION | ROHM & HAAS (US) | 2015-02-19 | — | — | US | disclosed |
| EP-2787821-A1 | ANTIMICROBIAL COMPOSITION | Unilever N.V. (NL) | 2014-10-15 | — | — | EP | disclosed |
| CN-104080342-A | Antimicrobial composition | UNILEVER NV | 2014-10-01 | — | — | CN | disclosed |
| WO-2013083594-A1 | ANTIMICROBIAL COMPOSITION | UNILEVER N.V. (NL) | 2013-06-13 | — | — | WO | disclosed |
| US-20110266361-A1 | PHEROMONE DISPENSER | BASF SE (DE) | 2011-11-03 | — | — | US | disclosed |
| US-20060155153-A1 | Methods for making(-)-menthol and oxygenated menthane compounds | AROMAGEN CORPORATION | 2006-07-13 | — | — | US | disclosed |
| US-4600581-A | TE-PINEOL, 2-HEXENAL AND BENZYL ALCOHOL | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 1986-07-15 | — | — | US | disclosed |
| US-4160786-A | USING COPPER CHROMITE CATALYST | SCM CORPORATION (US) | 1979-07-10 | — | — | US | disclosed |
| US-4058572-A | NICKEL CATALYSTS, STEREOSPECIFIC | SCM CORPORATION (US) | 1977-11-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150050220-A1 | ANTIMICROBIAL COMPOSITION | POLR1C, TMSB10, DPM1 | HIF1A 4079/4885EPAS1 3037/4885OPRM1 729/4885 |
| US-20260027136-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | CNR1, CNR2, OPRM1 | HIF1A 1370/4885EPAS1 4280/4885OPRM1 3/4885 |
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | TRPV1, SOST, RUNX1 | HIF1A 850/4885EPAS1 1268/4885OPRM1 1902/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.